Production (Stage)
Rennova Health, Inc.
RNVA
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 59.14% | -- | 135.53% | 190.79% | -200.80% |
| Total Depreciation and Amortization | -51.62% | -- | -19.43% | -9.03% | -13.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -358.49% | -- | -64.43% | -346.15% | 102.95% |
| Change in Net Operating Assets | -49.51% | -- | -40.02% | 136.83% | 24.69% |
| Cash from Operations | -660.78% | -- | 199.09% | 129.42% | 102.23% |
| Capital Expenditure | -5,066.67% | -- | -- | -- | -101.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.85% | -- | -146.58% | -67.93% | 50.92% |
| Cash from Investing | -127.13% | -- | -319.72% | -68.16% | -0.64% |
| Total Debt Issued | 100.00% | -- | -22.67% | -- | -- |
| Total Debt Repaid | -326.97% | -- | -53.76% | 38.79% | 85.01% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -130.06% | 337.24% |
| Cash from Financing | -120.86% | -- | -230.03% | -102.50% | -103.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -419.07% | -- | 60.05% | 24.30% | -187.87% |